Andrew Hopkins, PhD

Founder and CEO · Exscientia

Pharma & Life SciencesEuropeEstablished

Why follow Andrew

Offers visionary leadership perspectives on automated drug design, automated chemistry, and using patient-tissue-led platforms for oncology clinical trials.

Writes about

AI Drug DesignPrecision OncologyAutomated Chemistry

Best for

Computational chemists and precision medicine advocates